{"id":180,"date":"2019-11-25T15:59:47","date_gmt":"2019-11-25T19:59:47","guid":{"rendered":"http:\/\/blogs.duanemorris.com\/lifescienceslaw\/?p=180"},"modified":"2019-11-25T15:59:47","modified_gmt":"2019-11-25T19:59:47","slug":"fdas-bark-may-be-worse-than-its-bite-revised-guidance-permits-certain-compounding-of-animal-drugs-from-bulk-drug-substances","status":"publish","type":"post","link":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2019\/11\/25\/fdas-bark-may-be-worse-than-its-bite-revised-guidance-permits-certain-compounding-of-animal-drugs-from-bulk-drug-substances\/","title":{"rendered":"FDA&#8217;s Bark May Be Worse Than Its Bite: Revised Guidance Permits Certain Compounding of Animal Drugs from Bulk Drug Substances"},"content":{"rendered":"<p>On November 19, 2019, the U.S. Food and Drug Administration (FDA)\u00a0<a title=\"Compounding Animal Drugs from Bulk Drug Substances \" href=\"https:\/\/www.fda.gov\/media\/132567\/download\" target=\"_blank\" rel=\"noopener noreferrer\">released revised guidance<\/a>\u00a0concerning the compounding of animal drugs from bulk drug substances\u2014in particular, the circumstances under which the FDA would not plan to take enforcement action for certain violations of the Federal Food, Drug, and Cosmetic Act (FDCA) when pharmacists and veterinarians compound or oversee the compounding of animal drugs from bulk drug substances.\u00a0The guidance is intended to replace a withdrawn draft guidance concerning the compounding of animal drugs initially released in May 2015.<\/p>\n<p><a href=\"https:\/\/www.duanemorris.com\/alerts\/fdas_bark_worse_than_bite_revised_guidance_permits_certain_compounding_animal_drugs_1119.html\">View the full <em>Alert<\/em> on the Duane Morris LLP website<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>On November 19, 2019, the U.S. Food and Drug Administration (FDA)\u00a0released revised guidance\u00a0concerning the compounding of animal drugs from bulk drug substances\u2014in particular, the circumstances under which the FDA would not plan to take enforcement action for certain violations of the Federal Food, Drug, and Cosmetic Act (FDCA) when pharmacists and veterinarians compound or oversee &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2019\/11\/25\/fdas-bark-may-be-worse-than-its-bite-revised-guidance-permits-certain-compounding-of-animal-drugs-from-bulk-drug-substances\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;FDA&#8217;s Bark May Be Worse Than Its Bite: Revised Guidance Permits Certain Compounding of Animal Drugs from Bulk Drug Substances&#8221;<\/span><\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[415,416,29,209,64,388,298,119,418,417],"ppma_author":[521],"class_list":["post-180","post","type-post","status-publish","format-standard","hentry","category-uncategorized","tag-animals","tag-drug-compounding","tag-fda","tag-frederick-ball","tag-guidance","tag-justin-stern","tag-patrick-gallagher","tag-rick-ball","tag-vet-pharma","tag-vet-science"],"authors":[{"term_id":521,"user_id":6,"is_guest":0,"slug":"duanemorris3","display_name":"Duane Morris","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/843ff6e7a8fe5fc92109b47a45f34b6cf0ea499e6e788db23456c838b0ae6747?s=96&d=blank&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/comments?post=180"}],"version-history":[{"count":0,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/180\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/media?parent=180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/categories?post=180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/tags?post=180"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/ppma_author?post=180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}